Following a shocking investigation into South Africa's unregulated beauty economy, authorities are cracking down on the dangerous market for compounded weight-loss drugs like Ozempic and Mounjaro, aiming to protect public health from unregistered medicines.

As the rate of GLP-1 prescriptions in the U.S. has risen, the obesity rate has dropped.

The South Korean government is moving to tighten access to injectable obesity medications, closing prescription loopholes and cracking down on overseas purchase

Following a shocking investigation into South Africa's unregulated beauty economy, a new regulatory storm is brewing, targeting the dangerous market for compounded weight-loss…

Following a shocking investigation into South Africa's unregulated beauty economy, authorities are cracking down on the dangerous market for compounded weight-loss drugs like…

FOLLOWING an investigation into South Africa's aesthetics industry, the South African Health Products Regulatory Authority (SAHPRA), and South African Pharmacy Council (SAPC) have…